Accretive Health (NYSE:AH) Current price $9.40
The firm said Tuesday it will delay posting its financial results for the fourth quarter and full year 2012, along with its previously announced investor conference call set for February 27th, because it is examining the timing of revenue recognition for its revenue cycle management agreements. Accretive Health provides revenue cycle and quality of care services to healthcare providers.
Are these stocks a buy or sell? Let us help you decide. Check out our Stock Picker Newsletter now.